|
规格 |
|
| Agent: | Blasticidin |
| Formula Weight: | 458.9 g⁄mole |
| Product Line: | Gibco® |
| Reagent Type: | Antibiotic (Selective) |
| Shipping Condition: | Dry Ice |
| Validated Application: | Eukaryotic Selection⁄Stable Cell Line Generation, Bacterial Selection |
| Form: | Liquid |
| Concentration: | 10 mg⁄ml, 10 mg⁄mL, 10 mg⁄ml |
| Quantity: | 1 bottle |
| Sterility: | Sterile |
|
储存 |
|
|
Storage conditions: -5°C to -20°C (protect from light) Shipping conditions: Frozen Shelf life: 9 months from date of manufacture |
|
描述 |
Blasticidin S is a nucleoside antibiotic isolated from Streptomyces griseochromogenes. It is a potent inhibitor of protein synthesis in both prokaryotic and eukaryotic cells. Blasticidin S acts quickly by inhibiting peptide bond formation by the ribosome. Blasticidin S is used for the prevention of contamination of cell cultures. The recommended working concentration ranges from 2 to 20 µg/ml depending on the cell line. This product is provided as a solution at 10 mg/ml in 20 mM HEPES (pH 7.2-7.5). Life Technologies offers a variety of antibiotics and antimycotics for cell culture applications.
In addition, Blasticidin S is used as a bacterial selective antibiotic in the concentration range of 50–100 µg/ml. Resistance is conferred by expression of either one of two Blasticidin S deaminase genes: BSD (2) or bsr.These deaminases convert Blasticidin S to a nontoxic derivative. For selection purposes, the salt content of the LB medium must remain low (<90 mM) and the pH should not exceed 7.0 to maintain the activity of Basticidin S. Life Technologies also offers a variety of selection antibiotics.
Product Use
For Research Use Only: Not intended for animal or human diagnostic or therapeutic use.
cGMP Manufacturing
Gibco® Blasticidin S HCl is manufactured at a cGMP compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
